Correlation Between Expression of Cell Adhesion Molecules CD44 v6 and E-cadherin and Lymphatic Metastasis in Non-small Cell Lung Cancer |
Su, Chong-Yu
(Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University)
Li, Yun-Song (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) Han, Yi (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) Zhou, Shi-Jie (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) Liu, Zhi-Dong (Second Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University) |
1 | Kawano T, Yanoma S, Nakamura Y, et al (2005). Evaluation of soluble adhesion molecules (, , ), ICAM-1, and VCAM-1 astumor markers in head and neck cancer. Am J Otolaryngol, 26, 308-13. DOI |
2 | Kolesnik AP, Shevchenko AI, Tumanskii VA, et al (2013). Effect of the intercellular adhesion molecule E-cadherin on the prognosis of non-small cell lung cancer. Arkh Patol, 75, 30-3. |
3 | Li C, Hong W (2013). Research status and funding trends of lung cancer biomarkers. J Thorac Dis, 5, 698-705. |
4 | Li ZM, Ding ZP, Luo QQ, et al (2013). Prognostic significance of the extent of lymph node involvement in stage II-N1 nonsmall cell lung cancer. Chest, 144, 1253-60. DOI |
5 | Li CG, Huang XE, Xu L, et al (2012). Clinical application of serum tumor associated material (TAM) from non-small cell lung cancer patients. Asian Pac J Cancer Prev, 13, 301-4. 과학기술학회마을 DOI |
6 | Cui L, Liu XX, Jiang Y, et al (2014). Phase II Study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 1699-702. 과학기술학회마을 DOI ScienceOn |
7 | Amirghofran Z, Jalali SA, Hosseini SV, et al (2008). Evaluation of and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. J Gastrointest Cancer, 39, 73-8. DOI |
8 | Cazes A, Gibault L, Rivera C (2014). Lymphatic extension and lymphangiogenesis in non-small cell lung cancer. Rev Pneumol Clin, Epub ahead of print. |
9 | Chai LX, Sun KL, Guo LP, et al (2007). Expression of ezrin and -v6 in human esophageal squamous cell carcinoma and its clinical significance. Chin J Oncol, 29, 685-8. |
10 | Dursun P, Yuce K, Usubutun A, e al (2007). Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma. Int J Gynecol Cancer, 17, 843-50. DOI |
11 | Fei ZH, Yao CY, Yang XL, et al (2013). Serum BMP-2 upregulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pac J Cancer Prev, 14, 5293-9. DOI ScienceOn |
12 | Frixen UH, Behrens J, Sachs M, et al (1991). E-cadherinmediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol, 113, 173-85. DOI |
13 | Yin HT, Tian QZ, Guan L, et al (2013). In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev, 14, 1703-6. 과학기술학회마을 DOI ScienceOn |
14 | Warrington SJ, Strutt H, Strutt D et al (2013). The Frizzleddependent planar polarity pathway locally promotes E-cadherin turnover via recruitment of RhoGEF2. Development, 140, 1045-54. DOI ScienceOn |
15 | Wendt MK, Taylor MA, Schiemann BJ, et al (2011). Downregulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell, 22, 2423-35. DOI |
16 | Yan HA, Shen K, Huang XE, et al (2013). Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4801-4. 과학기술학회마을 DOI ScienceOn |
17 | Liotta LA, Stetler-Stevenson WG (1991). Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res, 51, 5054s-9s. |
18 | Yin HT, Zhang DG, Wu XL, et al (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12. 과학기술학회마을 DOI ScienceOn |
19 | Yip C, Cook GJ, Weeks A, et al (2014). Imaging assessment of lung tumor angiogenesis: insights and innovations. Semin Respir Crit Care Med, 35, 112-28. DOI ScienceOn |
20 | Lu YY, Huang XE, Xu L, et al (2013). Potential predictors of sensitivity to pemetrexed as first-line chemotherapy for patients with advanced non-squamous NSCLCs. Asian Pac J Cancer Prev, 14, 2005-8. 과학기술학회마을 DOI ScienceOn |
21 | Liu W, Li SY, Huang XE, et al (2012). Inhibition of tumor growth in vitro by a combination of extracts from Rosa roxburghii Tratt and Fagopyrum cymosum. Asian Pac J Cancer Prev, 13, 2409-14. 과학기술학회마을 DOI |
22 | Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection (Yadanzi(R)) combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4. 과학기술학회마을 DOI ScienceOn |
23 | Nentwich MF, Bohn BA, Uzunoglu FG, et al (2013). Lymphatic invasion predicts survival in patients with early nodenegative non-small cell lung cancer. J Thorac Cardiovasc Surg, 146, 781-7. DOI |
24 | Huang XE, Wei GL, Huo JG, et al (2013). Intrapleural or intraperitoneal lobaplatin for treatment of patients with malignant pleural effusion or ascites. Asian Pac J Cancer Prev, 14, 2611-4. 과학기술학회마을 DOI ScienceOn |
25 | Shiwu WU, Lan Y, Wenqing S, et al (2012). Expression and clinical significance of CD82/KAI1 and E-cadherin in nonsmall cell lung cancer. Arch Iran Med, 15, 707-12. |
26 | Sulzer MA, Leers MP, van Noord JA, et al (1998). Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer. Am J Respir Crit Care Med, 157, 1319-23. DOI ScienceOn |
27 | Tran TA, Kallakury BV, Sheehan CE, et al (1997). Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Hum Pathol, 28, 809-14. DOI ScienceOn |
28 | Gunthert U, Hofmann M, Rudy W, et al (1991). A new variant of glycoprotein confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24. DOI ScienceOn |
29 | Hou ZB, Lu KJ, Wu XL, et al (2014). In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment. Asian Pac J Cancer Prev, 15, 1767-9. 과학기술학회마을 DOI ScienceOn |
30 | Huang XE, Tian GY, Cao J, et al (2013). Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7. 과학기술학회마을 DOI ScienceOn |
31 | Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non- small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-5. 과학기술학회마을 DOI ScienceOn |